Burden of Cutaneous Lupus Erythematosus in Commercial vs. Publicly Insured Patients in the FDA’s Sentinel Distributed Database

This poster describes a project that assessed the impact of sociodemographic factors on CLE burden, we estimated CLE prevalence among commercially vs. publicly insured patients across sex and race strata in the FDA’s Sentinel Distributed Database (SDD). It was presented at the 2026 ISPE Annual Meeting.